Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2003
10/09/2003WO2003082870A1 Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082867A1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
10/09/2003WO2003082866A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082289A1 Process for the preparation of antiviral 7-azaindole derivatives
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191315 A chemical intermediate reaction by starting 2,6-diaminopyridine with malic acid and sulfuric acid, salt formation, hydroxylation, chlorination, dehydroxylation, reduction, esterification
10/09/2003US20030191164 Propane-1,3-dione derivatives
10/09/2003US20030191150 Process for producing tricyclic fused heterocyclic derivative
10/09/2003US20030191149 Compounds for treating fibromyalgia and chronic fatigue syndrome
10/09/2003US20030191145 Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and in cosmetics
10/09/2003US20030191143 Attenuation immunology response; antiproliferative agents; rheumatic diseases; hypotensive agents; antilipemic agents; anticholesterol agents
10/09/2003US20030191141 Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof
10/09/2003US20030191140 Psychological disorders; dissolving in solvent, crystallization
10/09/2003US20030191138 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191130 [1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists
10/09/2003US20030191129 Antitumor agents
10/09/2003US20030191124 Derivatives of sulphonamides, their preparation and use as medicaments
10/09/2003US20030191115 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191091 Use of riboflavin and flavin derivatives as chitinase inhibitors
10/09/2003US20030190540 Photoconductive layer containing azo compound; electrostaticlatent image
10/09/2003CA2480869A1 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003CA2480695A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2479644A1 Imidazo fused compounds
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349835A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions and uses thereof
10/08/2003EP1349548A2 Methods and compositions for treating periodontal disease
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists
10/08/2003EP1070068B1 Granulatimide derivatives for use in cancer treatment
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003CN1447843A Functionalized perylene tetracarboxylic acid diimides
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447809A Medicines for prevention and treatment of neurodegenerative diseases
10/08/2003CN1447693A Use of angiotensin Ôàí antagonists
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630588 Dye labeled imidazoquinoline compounds
10/07/2003US6630487 Treatment of insulin resistance with growth hormone secretagogues
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630484 6-and 7-substituted analogs of swainsonine their preparation and therapeutic use
10/07/2003US6630482 CFTR channel activator compounds and pharmaceutical compositions containing same
10/07/2003US6630481 Phototherapeutic and catalytic photoactivated DNA cleaving agents
10/07/2003US6630472 Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation
10/07/2003US6630467 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/02/2003WO2003080760A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
10/02/2003WO2003080612A1 Dipyridodiazepinones as reverse transcriptase inhibitors
10/02/2003WO2003080611A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
10/02/2003WO2003080610A1 Imidazopyridine derivatives as kinase inhibitors
10/02/2003WO2003080609A1 Pyrazolopyrimidines derivatives
10/02/2003WO2003080608A2 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003WO2003080606A1 Process for preparing a pharmaceutically active compound (granisetron)
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080573A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003WO2003080125A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
10/02/2003WO2003080112A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003WO2003039529A8 Selective antibacterial agents
10/02/2003WO2003016316A8 Diazacycloalkanes as oxytocin agonists
10/02/2003WO2002018303A3 Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003US20030187258 Bactericides
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187026 Antiproliferative agents
10/02/2003US20030187023 Sulfone derivatives, process for their production and use thereof
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187016 Viricides; anticancer agents
10/02/2003US20030187014 Condensed pyrazole derivatives, process for producing the same and use thereof
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186986 Agent for improving learning or memory
10/02/2003US20030186985 Oxyiminoalkanoic acid derivatives
10/02/2003US20030186970 Androgen receptor modulator compounds and methods
10/02/2003US20030186969 Benzodiazepine derivatives
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186949 Modulate immunology response; anticancer agents
10/02/2003CA2484044A1 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003CA2481703A1 Process for preparing granisetron
10/02/2003CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2480039A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/02/2003CA2477771A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/01/2003EP1347974A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
10/01/2003EP1347973A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
1 ... 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 ... 646